All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Thu 1981-04-30? to Thu 2026-04-02 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| NVO × |
−24.65%
2026-04-02 |
441.29 TR
2026-04-02 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Thu 1981-04-30? to Thu 2026-04-02 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| NVO × |
+44,028.88%
+14.52%/yr |
+18.56%/yr
(R2=0.975) |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Thu 1981-04-30? to Thu 2026-04-02 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| NVO × |
$10,000.00
1981-04-30 |
$4,412,887.83
2026-04-02 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Year | NVO |
|---|---|
| 2026 (YTD) | −24.65% |
| 2025 | −39.22% |
| 2024 | −15.94% |
| 2023 | +54.84% |
| 2022 | +22.66% |
| 2021 | +63.52% |
| 2020 | +23.33% |
| 2019 | +28.70% |
| 2018 | −12.12% |
| 2017 | +54.23% |
| 2016 | −36.56% |
| 2015 | +39.39% |
| 2014 | +16.67% |
| 2013 | +15.41% |
| 2012 | +44.09% |
| 2011 | +3.91% |
| 2010 | +79.50% |
| 2009 | +26.98% |
| 2008 | −19.73% |
| 2007 | +57.38% |
| 2006 | +51.05% |
| 2005 | +5.27% |
| 2004 | +34.63% |
| 2003 | +43.96% |
| 2002 | −27.23% |
| 2001 | +14.20% |
| 2000 | +38.75% |
| 1999 | −2.01% |
| 1998 | −7.34% |
| 1997 | +55.13% |
| 1996 | +38.17% |
| 1995 | +45.42% |
| 1994 | −3.53% |
| 1993 | +12.20% |
| 1992 | −0.12% |
| 1991 | +44.64% |
| 1990 | +26.22% |
| 1989 | +30.77% |
| 1988 | +84.44% |
| 1987 | −34.20% |
| 1986 | +12.96% |
| 1985 | +25.12% |
| 1984 | −57.38% |
| 1983 | +28.35% |
| 1982 | +10.15% |
| 1981 | +24.58% |
| Thu 1981-04-30? to Thu 2026-04-02 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| NVO × | −73.09% |
−74.70%
2026-03-27 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||